JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home


619 *	Thu, 8/2/2012, 8:30 AM - 10:20 PM	CC-Room 23B
Methodologies Related to Dose Response/Dose Finding — Contributed Papers
Biopharmaceutical Section
Chair(s): James Jiao, Janssen Pharmaceuticals R&D
8:35 AM	A Dose-Finding Design with Time-to-Toxicity Endpoint — Rui Qin, Mayo Clinic ; Xian-Jin Xie, The University of Texas Southwestern Medical Center at Dallas
8:50 AM	Interim Pharmacokinetic Assessment Using a Bayesian Decision Analysis in Phase II Clinical Trials — Bo Jin, Pfizer Inc. ; Keying Ye, The University of Texas at San Antonio
9:05 AM	Preliminary Assessment of MCPMod for Dose-Response Modeling — James Reynolds ; Joseph Gao, Shire Development Inc.
9:20 AM	Use of Order-Restricted Simultaneous Inferences in Clinical Dose Study Data Analysis — Gang Jia, Merck Research Laboratories
9:35 AM	Biological Optimum Dose-Finding Trials for Cancer Targeted Agents — Hao Liu, Baylor College of Medicine
9:50 AM	Analysis of High-Throughput Screening (HTS) Assay Data Based on Preliminary Test Inference — Changwon Lim, Loyola University Chicago ; Pranab K. Sen, The University of North Carolina at Chapel Hill ; Shyamal Peddada, National Institute of Environmental Health Sciences
10:05 AM	Classification of Dose-Response Curves in Cell-Based In Vitro Assay for Toxicity Evaluation of Heterogeneous Compounds — Donghui Zhang, Sanofi U.S. Inc. ; Chunpeng Fan, Sanofi U.S. Inc.

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.